Evidence-Driven
Research at Scale
500+
Studies Published
40+
Active Trials
IRB
Approved Protocol
100%
Open Access
Re·search
The systematic investigation into and study of materials, sources, and clinical phenomena in order to establish facts, validate hypotheses, and advance the standards of precision medicine.
Focus Areas
Biomarker discovery, translational science, clinical trial design, real-world evidence, and outcomes research, all anchored in IRB-approved, peer-reviewed standards of inquiry.
The Research at the American Board of Precision Medicine drives the evidence base that underpins clinical certification generating and synthesizing knowledge across multi-omics, therapeutics, and population health to inform standards that physicians can trust.
From biomarker discovery and translational studies to large-scale clinical trials and real-world outcomes analysis, this department connects bench science to boardroom policy ensuring every standard ABOPM sets is grounded in rigorous, reproducible evidence.
Research at ABOPM is not peripheral - it is the engine of credibility that keeps precision medicine standards current, defensible, and clinically meaningful.
500+
Studies Published
40+
Active Trials
IRB
Approved Protocol
Where Evidence Meets
Clinical Certainty
The Research at ABOPM exists at the intersection of scientific inquiry and clinical practice generating the rigorous, reproducible evidence that drives certification standards, informs physician training, and advances the field of precision medicine.
Identifying and validating biological markers that predict disease onset, progression, and therapeutic response building the molecular evidence base for precision diagnostics and targeted treatment.
Designing and overseeing IRB-approved studies that test precision medicine interventions at scale from early-phase translational research to real-world outcomes analysis across diverse patient populations.
Accelerating the journey from bench discovery to bedside application synthesizing multi-omics data, population studies, and clinical evidence into actionable standards physicians can apply today.
"Research is not what happens before medicine - it is the engine that keeps medicine honest, current, and worthy of patient trust. At ABOPM, every standard we set begins with evidence."
American Board of Precision Medicine · Research Department
Shaping the Future
of Precision Medicine
As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.
The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.
Insights Shaping
Precision Medicine
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
Digital Biomarkers and Wearable Health Data
Explore how digital biomarkers and wearable technologies are enabling continuous health monitoring, early disease detection, and more personalized approaches to precision medicine. ...more
On the Frontier
October 15, 2026•8 min read
From Lab Report to Treatment Plan: Interpreting Molecular Diagnostics
Explore how clinicians interpret molecular diagnostic reports and translate genomic, transcriptomic, and proteomic findings into informed, personalized treatment decisions. ...more
Precision Medicine in Action
October 08, 2026•8 min read
Biomarkers That Matter: The Molecular Signals Guiding Oncology Treatment
Discover how molecular biomarkers such as HER2, KRAS, and PD-L1 are helping guide treatment selection, clinical trials, and personalized cancer care. ...more
Precision Oncology
October 01, 2026•8 min read
Stay at the Forefront of Precision Medicine
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.
COMPANY
RESOURCES
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.